Obstructive sleep apnea may increase the risk of Alzheimer's disease
Open Access
- 5 September 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (9) , e0221255
Abstract
Amyloid-β 1–40 (Aβ 1–40) and amyloid-β 1–42 (Aβ 1–42) are the proteins known to be involved in the pathogenesis of Alzheimer’s disease (AD)–the most common cause of dementia in the elderly. Hypoxia is suspected to be one of conditions associated with Aβ plasma level increase. A common reason of hypoxia is obstructive sleep apnea (OSA), characterized by recurrent episodes of apnea. The aim of the study was to evaluate plasma Aβ 1–40 and Aβ 1–42 concentrations in patients with OSA. Patients with suspected OSA (n = 112) underwent polygraphic examinations Patients with confirmed OSA (n = 81) showed apnea/hypopnea index greater than or equal to 5. Mild and moderate form of the disease was defined when AHI was 5–30 (n = 38, OSA+), severe–when AHI was >30 (n = 43, OSA++). Individuals with AHI<5 (n = 31) served as control group (OSA-). Aβ 1–40 concentrations in OSA++ (191.1 pg/ml) group was significantly (p<0.05) higher compared with OSA- (76.9 pg/ml) and OSA+ (159.4 pg/ml) and correlated with selected parameters of hypoxemia severity. There were no differences in Aβ 1–42 concentration between the groups. In patients with severe OSA Aβ 1–40 plasma concentrations are significantly higher compared with OSA- and OSA+ and seem to be related to hypoxia severity, which may indicate increased risk of AD development in this group of patients.Keywords
This publication has 22 references indexed in Scilit:
- Amyloid‐β efflux from the central nervous system into the plasmaAnnals of Neurology, 2014
- The amyloid precursor protein: A biochemical enigma in brain development, function and diseaseFEBS Letters, 2013
- The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive ImpairmentCold Spring Harbor Perspectives in Medicine, 2012
- Distinguishing Alzheimer’s disease from other major forms of dementiaExpert Review of Neurotherapeutics, 2011
- Effects of Hypoxia and Oxidative Stress on Expression of Neprilysin in Human Neuroblastoma Cells and Rat Cortical Neurones and AstrocytesNeurochemical Research, 2007
- Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expressionProceedings of the National Academy of Sciences, 2006
- Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort studyThe Lancet Neurology, 2006
- Plasma Aβ40 and Aβ42 and Alzheimer’s diseaseNeurology, 2003
- BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeuticsHuman Molecular Genetics, 2001
- Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral ArteriesJournal of Neurochemistry, 1996